<DOC>
	<DOCNO>NCT02036281</DOCNO>
	<brief_summary>The subject treat single dose SP-SAP . They receive study drug SP-SAP via percutaneous intraspinal catheter , monitor 4 hour require stay hospital 24 hour precautionary care . Their vital sign monitor record immediately follow injection . After catheter remove , follow assessment make physical exam include motor sensory function , electrocardiogram . A neurologist available consultation need . Beginning dose SP-SAP 1 -mcg first cohort . Subsequent single patient dose cohort 2 , 4 , 8 , 16 , 32 , 64 90 mcg intrathecally ( spine ) . SP-SAP accrue treated four week observation toxicity cohort . Study duration 6 month start SP-SAP administration .</brief_summary>
	<brief_title>A Phase 1 Study Substance P-Saporin Terminal Cancer Patients With Intractable Pain</brief_title>
	<detailed_description>Screening ( -7 day Day 0 ) - Physical exam medical history ; - Vital sign ; - Blood test ; - Pain measurement ( 6 daily pain questionnaire 7 day prior receive study drug ) ; - Urine test ; - Pregnancy test ; - Electrocardiogram ( EKG ) , trace electrical activity heart ; - Collection demographic information ( age , sex , ethnic origin ) ; Study Drug : SP-SAP administered via spinal injection . Depending subject enrol study , dose SP-SAP 1 90 microgram SP-SAP Therapy : Subject arrive UTSW Eugene McDermott Center Pain Management 2 hour prior treatment . The follow take place : - Physical exam ; - Pain measurement ( 6 pain questionnaire ) ; - EKG ; - The subject catheter insert spine receive study drug intrathecally ( spine ) . The catheter remain spine 4 hour . Less 1 tablespoon spinal fluid collect research purpose ; - They remain University Texas Southwestern Medical Center Hospital 24 hour observation precaution . Follow-Up occur weekly 8 week monthly 4 month need . During visit follow take place : - Physical exam ( include sensory motor skill ) medical history ; - Vital sign ; - Two tablespoon blood draw arm needle stick blood test ; - Pain measurement ( 6 pain questionnaire ) ; - Urine test ; - Electrocardiogram ( EKG ) , trace electrical activity heart . The subject ask keep diary record nausea vomit well medication log record pain medication dosage take visit . Each visit take approximately 2 hour complete 4 Month Follow-Up Informational data level pain , adverse event , sensory motor function collect remain 4 month study time death . This information may collect via patient diary , office visit telephone interview .</detailed_description>
	<mesh_term>Pain , Intractable</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<mesh_term>Saporin</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Signed informed consent 3 . Terminally ill cancer patient intractable chronic pain pelvis , low abdomen , back , spine . `` Terminal '' refers ≤ sixmonth life expectancy . `` Intractable '' define pain uncontrolled medication procedure . 4 . Minimal expect survival time one month 5 . ECOG Performance status 0 3 6 . Able verbally report pain 7 . Able indicate pain VAS 8 . Able perform motor/sensory test 9 . Able undergo 4h intrathecal catheter placement 10 . Other therapeutic palliative option exhaust 1 . Concurrent therapy investigational agent 2 . Concurrent radiation chemotherapy 3 . Pregnancy failure use effective contraception fertile male female , breastfeed female . For female patient childbearing potential , negative pregnancy test ( serum urine ) within ten day start study treatment must obtain . Female patient must agree use effective contraception , must surgically sterile , must postmenopausal . Acceptable form birth control : spermicide condom , diaphragm , cervical cap , IUDintrauterine device , birth control pill , abstinence . The rhythm method Plan B consider acceptable form birth control . Male patient must agree use effective contraception surgically sterile . 4 . Diagnosis intractable chronic pain chest , head , neck upper extremity . 5 . Active infection ulcer lumbar injection site 6 . Inability receive lumbar intrathecal injection factor 7 . Diagnosis meningitis encephalitis 8 . Other severe , acute chronic medical psychiatric condition may increase risk associate study participation , judgment investigator , would make patient inappropriate study 9 . Comorbidities particular risk ( i.e. , CNS , CNS metastases , hydrocephalus coagulopathy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Terminally ill , histologically-confirmed advance cancer</keyword>
	<keyword>Pain unrelieved opioids</keyword>
</DOC>